NCT06244940View on ClinicalTrials.gov

The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 9, 2024

Primary Completion Date

April 1, 2026

Study Completion Date

October 1, 2026

Conditions
Congenital Heart Disease
Interventions
DIAGNOSTIC_TEST

Whole Genome Sequencing (WGC) from subject samples

Perform whole genome sequencing (WGS) on fetuses with prenatally detected congenital heart disease (CHD) who meet inclusion criteria. Assess diagnostic yield of WGS in CHD and effect of prenatal versus postnatal phenotype on diagnostic yield.

Trial Locations (1)

92123

RECRUITING

Rady Children's Institute for Genomic Medicine, San Diego

All Listed Sponsors
lead

Scripps Translational Science Institute

OTHER